We are live on ! Find out more
BIOC

Biocept, Inc.

Delisted

BIOC was delisted on the 24th of October, 2023.

12 hedge funds and large institutions have $1.36M invested in Biocept, Inc. in 2015 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% less funds holding

Funds holding: 1712 (-5)

49% less capital invested

Capital invested by funds: $2.67M → $1.36M (-$1.31M)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 5

Holders
12
Holders Change
-5
Holders Change %
-29.41%
% of All Funds
0.31%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
3
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Barclays
26
Barclays
United Kingdom
-$43K -1 Closed
HR
27
Howe & Rusling
New York
-$2K

BIOC Hedge Fund Activity: Q4 2015 in Review

12 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q4 2015, worth a combined $1.36M — down 49% from $2.67M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of BIOC and 0 opened new positions — a net loss of 5 holders — while 3 trimmed existing stakes and 1 added.

The largest buyer was Vanguard Group, adding an estimated $53.1K. The largest seller was Bank of America, cutting an estimated $106K.

  • 12 institutional investors held Biocept, Inc. (BIOC) as of Q4 2015, down from 17 in Q3 2015.
  • Funds reported $1.36M of Biocept, Inc. stock for Q4 2015, down 49% quarter-over-quarter.
  • 0 funds opened new Biocept, Inc. positions in Q4 2015 and 5 closed out, a net change of -5 holders.
  • The largest Biocept, Inc. buyer in Q4 2015 was Vanguard Group, an estimated $53.1K added.
  • The largest Biocept, Inc. seller in Q4 2015 was Bank of America, an estimated $106K sold.

Based on aggregated 13F filings for Q4 2015.